Top News

Dr. Lal Pathlabs is currently trading at Rs 3448.65, up by 60.80 points or 1.79% from its previous closing of Rs 3387.85 on the BSE.

The scrip opened at Rs 3380.95 and has touched a high and low of Rs 3496.75 and Rs 3380.95 respectively. So far 9807 shares were traded on the counter.

The BSE group ‘A’ stock of face value Rs 10 has touched a 52-week high of Rs 3645.00 on 10-Oct-2024 and a 52-week low of Rs 2295.10 on 03-Mar-2025.

Last one week high and low of the scrip stood at Rs 3504.05 and Rs 3261.30 respectively. The current market cap of the company is Rs 28817.52 crore.

The promoters holding in the company stood at 53.79%, while Institutions and Non-Institutions held 39.47% and 6.74% respectively.

Dr. Lal Pathlabs has become the first laboratory in the country to adopt a deep learning-based AI module to detect lymph node metastasis, including micrometastasis, in cancer cases. This cutting-edge technology, validated in collaboration with Qritive, was showcased at USCAP 2025 one of the world’s leading pathology conferences. Detecting micrometastases – tiny clusters of cancer cells in lymph nodes – usually takes a lot of time and special tests. The AI tool QiAI Lymph Node Dx changes that by using deep learning to quickly and accurately spot cancer cells on digital slides. Adding this technology to regular medical practice makes diagnosing cancer faster and more reliable.

The AI system was tested on digital slides from breast, colon, stomach, and esophageal cancer cases. It accurately detected single-cell and micrometastases that had been missed during manual reviews. These results were later validated through immunohistochemistry (IHC), confirming the system’s reliability.

Dr. Lal Pathlabs is a provider of diagnostic and healthcare tests and services in India.

Bhupendra singh chundawat is a seasoned technology journalist with over 22 years of experience in the media industry. He specializes in covering the global technology landscape, with a deep focus on manufacturing trends and the geopolitical impact on tech companies. Currently serving as the Editor at Udaipur kiranhis insights are shaped by decades of hands-on reporting and editorial leadership in the fast-evolving world of technology.